Clinical Trials Browser

Phase 1/2 × Advanced Solid Tumours × sintilimab × Clear all

NCT05804526 2024-04-30

A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumours